![]() |
市場調查報告書
商品編碼
1965370
低溫滅菌市場-全球產業規模、佔有率、趨勢、機會與預測:按產品、設備、地區和競爭對手分類,2021-2031年Low Temperature Sterilization Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product, By Device (Endoscopes, Laparoscopic Kit, Ophthalmology, Otolaryngology, Others), By Region & Competition, 2021-2031F |
||||||
全球低溫滅菌市場預計將從 2025 年的 33.9 億美元大幅成長至 2031 年的 61.1 億美元,複合年成長率為 10.32%。
這種滅菌方法使用過氧化氫氣體等離子體和環氧乙烷等化學試劑,去除無法承受高溫高濕環境的醫療設備上的微生物。市場成長的主要驅動力是複雜內視鏡和手術器械的日益普及,這些器械需要嚴格的再處理,且不能受到熱損傷。此外,旨在減少醫院感染的感染控制通訊協定日益重要,也使得全球醫療機構對這些專業滅菌技術的需求持續成長。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 33.9億美元 |
| 市場規模:2031年 | 61.1億美元 |
| 複合年成長率:2026-2031年 | 10.32% |
| 成長最快的細分市場 | 環氧乙烷滅菌器 |
| 最大的市場 | 北美洲 |
根據美國醫療器材協會(AdvaMed)預測,到2024年,美國約有一半的醫療設備將使用環氧乙烷進行滅菌,年滅菌量將達到200億件。儘管環氧乙烷的應用大規模,但由於有毒滅菌劑排放的嚴格環境法規,該市場仍面臨許多挑戰。這些法規要求可能迫使相關機構安裝昂貴的排放控制系統,從而限制現有滅菌中心的運作能力,並阻礙市場整體成長。
微創手術技術的日益普及推動了全球低溫滅菌市場的發展,因為對精密器械的再處理產生了迫切需求。與傳統的醫用不銹鋼器械不同,這些手術中使用的光纖內視鏡和機械臂包含敏感的電子元件和熱不穩定的聚合物,這些材料在蒸氣高壓釜下劣化,因此必須採用過氧化氫蒸氣等低溫滅菌方法。手術數量的增加直接提高了對相容滅菌循環的日常運作需求,以確保高處理能力。根據直覺外科公司(Intuitive Surgical)截至2025年1月的會計年度收益報告,2024年全球達文西手術數量年增約17%,同時需要特殊處理的複雜醫療設備庫存也顯著增加。
此外,醫療設備安全機構加強對醫療器材再處理標準的監管,對熱敏性和濕敏性醫療設備的滅菌需求不斷成長,這也推動了市場發展。可重複使用器械的複雜結構容易殘留有機物,因此有效的低溫滅菌對於維持器械完整性和預防感染至關重要。為了佐證這項需求,醫療設備評估研究所 (ECRI) 於 2024 年 2 月發布的《醫療保健技術風險報告》將不充分或繁瑣的器材清潔程序列為醫療機構面臨的第二大風險。為了因應這些嚴格的安全標準,服務提供者正在不斷提升自身的服務能力。例如,Sotera Health 在 2025 年報告稱,其 Sterigenics 部門在 2024 年全年實現了 6.98 億美元的收入淨額,這反映了該行業對基本滅菌服務的持續需求。
對有毒滅菌劑(尤其是環氧乙烷)排放的嚴格法規環境,對全球冷凍保存市場的成長構成重大阻礙。隨著環保機構實施嚴格的空氣品質標準以保護公眾健康,滅菌設施必須安裝昂貴的排放控制系統和連續監測技術。這些合規要求給服務提供者帶來了沉重的營運和資本負擔,擠佔了原本可用於技術創新和產能擴張的資金。因此,合規成本的增加限制了市場的整體營運柔軟性,並削弱了小規模設施的競爭力。
除了經濟影響外,這些法規也對現有供應鏈能力構成直接威脅。執行更嚴格的排放限制通常需要對設施維修,導致無法滿足新標準的設施長期運作或永久關閉。運轉率會造成嚴重的瓶頸,使市場難以充分應對不斷成長的醫療設備需求。據先進醫療技術協會 (AdvaMed) 稱,擬議的將在 2024 年最終確定的環境法規可能會使全國環氧乙烷滅菌能力下降 30% 至 50%,這凸顯了監管壓力將對市場供應造成多麼嚴重的衝擊。
受企業自身部門監管合規要求日益複雜的推動,市場正顯著轉向策略性外包滅菌服務。醫療設備製造商和醫院不再投入大量資金維修設施以符合環氧乙烷等化學品的嚴格排放法規,而是擴大與擁有專業基礎設施、能夠安全管理危險化學品的第三方供應商簽訂合約。這種模式使企業能夠利用外部在各種滅菌方法方面的專業知識,同時將固定監管成本轉化為變動成本。例如,STERIS plc 在 2025 年 2 月發布的報告顯示,其應用滅菌技術部門的收入成長了 10%,達到 2.581 億美元,這反映出工業領域對外部滅菌合作夥伴的依賴程度日益提高。
同時,二氧化氮滅菌技術作為一種永續的溫敏複合材料滅菌方案,正迅速發展。此方法特別適用於生物可吸收植入和預填充式注射器,其超低溫操作可確保藥物的完整性。在傳統過氧化氫蒸氣滅菌可能達到其滲透極限的情況下,這一點至關重要。該技術所需通氣量極低且循環時間短,進一步加速了其應用,為業界提供了高效、低排放量的滅菌解決方案。根據2025年9月發布的新聞稿,Noxylizer已獲得3,000萬美元的成長資金,用於支持業務擴張和這項報廢滅菌替代技術的全球推廣。
The Global Low Temperature Sterilization Market is projected to expand significantly, rising from a valuation of USD 3.39 Billion in 2025 to USD 6.11 Billion by 2031, reflecting a compound annual growth rate of 10.32%. This sterilization method employs chemical agents, such as hydrogen peroxide gas plasma or ethylene oxide, to eradicate microbial life from medical devices that cannot withstand high heat or moisture. The primary catalyst for this market growth is the increasing prevalence of intricate endoscopes and surgical instruments that demand rigorous reprocessing without incurring thermal damage. Additionally, the heightened emphasis on infection control protocols aims to reduce hospital-acquired infections, thereby generating a continuous demand for these specialized sterilization technologies in medical facilities worldwide.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 3.39 Billion |
| Market Size 2031 | USD 6.11 Billion |
| CAGR 2026-2031 | 10.32% |
| Fastest Growing Segment | Ethylene Oxide Sterilizers |
| Largest Market | North America |
According to AdvaMed, in 2024, ethylene oxide was utilized for approximately half of all sterile medical devices in the United States, representing an annual volume of 20 billion items. Despite this massive utilization, the market faces significant hurdles due to strict environmental regulations regarding the emission of toxic sterilizing agents. These regulatory mandates compel facilities to install expensive emission control systems, which can limit the operational capacity of existing sterilization centers and hinder broader market growth.
Market Driver
The rising adoption of minimally invasive surgical techniques drives the Global Low Temperature Sterilization Market by creating a critical need for reprocessing delicate instrumentation. Unlike conventional stainless-steel tools, the fiber-optic endoscopes and robotic arms utilized in these procedures feature sensitive electronics and heat-labile polymers that degrade under steam autoclaving, necessitating the use of low-temperature methods like vaporized hydrogen peroxide. This increase in surgical volume directly boosts the daily operational requirement for compatible sterilization cycles to ensure high throughput. According to Intuitive Surgical's January 2025 financial results, worldwide da Vinci procedures grew by approximately 17% in 2024 compared to the prior year, highlighting the growing inventory of complex devices that require specialized processing.
Furthermore, the market is propelled by the increasing demand for sterilizing heat-sensitive and moisture-sensitive medical devices, as safety organizations heighten their scrutiny of reprocessing standards. The complex architecture of reusable instruments often traps organic residue, making effective low-temperature sterilization essential for preventing infections while preserving equipment integrity. Underscoring this necessity, the ECRI's February 2024 report on health technology hazards ranked inadequate or burdensome device cleaning instructions as the second-highest risk facing healthcare organizations. To comply with these rigorous safety standards, providers are maintaining robust service capacities; for instance, Sotera Health reported in 2025 that its Sterigenics segment achieved full-year 2024 net revenues of $698 million, reflecting continued industrial demand for essential sterilization services.
Market Challenge
The rigorous regulatory environment controlling the emissions of toxic sterilizing agents, specifically ethylene oxide, presents a substantial obstacle to the growth of the Global Low Temperature Sterilization Market. As environmental agencies implement strict air quality standards to safeguard public health, sterilization facilities are required to install costly emission control systems and continuous monitoring technologies. These compliance mandates place heavy operational and capital burdens on service providers, redirecting financial resources that might otherwise support technological innovation or capacity expansion. Consequently, the elevated costs associated with compliance limit the market's overall operational flexibility and hinder the ability of smaller facilities to remain competitive.
Beyond the financial implications, these regulations pose a direct threat to existing supply chain capacities. Enforcing tighter emission limits often requires facility retrofitting, which results in prolonged operational downtime or the permanent closure of centers unable to adhere to the new standards. This decrease in operational availability generates severe bottlenecks, making it difficult for the market to adequately handle the increasing volume of medical devices. According to the Advanced Medical Technology Association (AdvaMed), finalized environmental proposals in 2024 were projected to potentially decrease nationwide ethylene oxide sterilization capacity by 30 to 50 percent, highlighting the profound impact regulatory pressures have on market availability.
Market Trends
The market is experiencing a notable shift towards the strategic outsourcing of sterilization services, influenced by the growing complexity of regulatory compliance for in-house departments. Instead of investing capital to retrofit facilities for stringent emission controls on agents like ethylene oxide, device manufacturers and hospitals are increasingly contracting third-party vendors equipped with the specialized infrastructure to safely manage hazardous chemistries. This model enables organizations to transform fixed regulatory costs into variable expenses while utilizing external expertise for various sterilization modalities. Evidencing this trend, STERIS plc reported in February 2025 that revenue for its Applied Sterilization Technologies segment rose by 10 percent to $258.1 million, reflecting the industrial sector's growing reliance on outsourced sterilization partners.
Concurrently, nitrogen dioxide sterilization technology is gaining momentum as a sustainable option for temperature-sensitive combination products. This method is especially effective for bio-absorbable implants and pre-filled syringes, as it functions at ultra-low temperatures that maintain drug integrity-a crucial requirement where traditional vaporized hydrogen peroxide may encounter penetration limitations. The uptake of this technology is further hastened by its minimal aeration needs and rapid cycle times, offering a solution that supports the industry's drive for efficient, low-emission sterilants. According to a September 2025 press release, Noxilizer, Inc. secured $30 million in growth capital to expand its operations and support the rising global adoption of this terminal sterilization alternative.
Report Scope
In this report, the Global Low Temperature Sterilization Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Low Temperature Sterilization Market.
Global Low Temperature Sterilization Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: